Conference Coverage
Conference Coverage
‘Dramatic’ Phase 2 Results for Survodutide in MASH, Fibrosis
Fifty percent of patients on 2.4- and 6-mg doses experienced a statistically significant improvement in fibrosis without worsening of MASH.
Conference Coverage
Seladelpar Shows Clinically Meaningful Improvements in PBC
The 2-year analysis also showed that seladelpar, a first-in-class, orally active agent, was safe and well tolerated.
Conference Coverage
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Tirzepatide also led to weight loss in patients.
Conference Coverage
Should ctDNA guide clinical decisions in GI cancers?
Data are maturing for colon cancer and emerging for pancreatic cancer, but experts say more work needs to be done.
Conference Coverage
Women with Autoimmune Liver Diseases Still Face Increased CVD Risks
Women with autoimmune hepatitis had a significantly higher cardiovascular risk compared to women without autoimmune hepatitis.
Conference Coverage
Intelligent Liver Function Testing Helps Detect, Diagnose Chronic Liver Disease
The iLFT platform uses an automated algorithm that analyzes standard liver function test results.
Conference Coverage
FMT Could Prevent Recurrence of Hepatic Encephalopathy in Patients With Cirrhosis
Standard treatment with lactulose and rifaximin often results in a lack of patient response.
AGA Tech Summit
Advice, Support for Entrepreneurs at AGA Tech 2024
Medical entrepreneurship is a hard road, but AGA is ramping up its support for the GI space.
Conference Coverage
Emerging Evidence Supports Dietary Management of MASLD Through Gut-Liver Axis
Dietary fats were most consistently associated with inflammatory markers, with inflammation being positively associated with saturated fats and...
Conference Coverage
Spondyloarthritis Screening Study Finds ‘High Burden of Need’ in Patients With Inflammatory Bowel Disease
More than 40% of patients with IBD screened positive for joint pain in a multicenter study, yet few patients had seen a rheumatologist in the past...